The Diffusion of a Novel Therapy Into Clinical Practice
Authors:
- Leslie R. HarroldLHLeslie R. Harrold
- Jerry H. GurwitzJGJerry H. Gurwitz
- Terry S. FieldTFTerry S. Field
- Susan E. AndradeSASusan E. Andrade
- Leslie S. FishLFLeslie S. Fish
- P. David JarryPJP. David Jarry
- Robert A. YoodRYRobert A. Yood
Open Access
- 11 December 2000
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 160 (22) , 3401-3405
Abstract
ERECTILE DYSFUNCTION is a common condition that is thought to affect between 20 and 30 million men in the United States,1 the majority of whom have never sought medical attention for the problem.2 With the availability of sildenafil (Viagra), there has been unprecedented public interest in the treatment of this condition.3 In the first 3 months that sildenafil was on the market, 3.9 million prescriptions were dispensed.4 The medication is even available for purchase over the Internet.5,6 The introduction of an effective oral medication has shifted the treatment of erectile dysfunction from specialists to primary care physicians.7 Most specialists in male impotence consider sildenafil the first-line therapy for erectile dysfunction.7Keywords
This publication has 15 references indexed in Scilit:
- Direct Sale of Sildenafil (Viagra) to Consumers over the InternetNew England Journal of Medicine, 1999
- New drug for erectile dysfunction boon for many, "viagravation" for some.JAMA, 1998
- Why Are Physicians Not Prescribing Diuretics More Frequently in the Management of Hypertension?JAMA, 1998
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Sildenafil: medical advance or media event?The Lancet, 1998
- Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure1997
- Innovation in high risk drug therapySocial Science & Medicine, 1994
- Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging StudyJournal of Urology, 1994
- Differences among practitioners in patterns of preference for information sources in the adoption of new drugsSocial Science & Medicine, 1984
- Scientific versus commercial sources of influence on the prescribing behavior of physiciansThe American Journal of Medicine, 1982